by Chris Kamel | Oct 14, 2010
The reprogramming of differentiated adult cells into induced pluripotent stem (iPS) cells is accomplished by the expression of a small number of key genes. This is typically done by introducing DNA either by transfection or with viral vectors. Current methods,...
by Katie Moisse | Oct 6, 2010
Day two of the World Stem Cell Summit featured a much-anticipated update on a groundbreaking clinical trial launched in January to assess the safety and feasibility of injecting fetal stem cells into the spinal cords of people with Amyotrophic Lateral Sclerosis (ALS)....
by Stem Cell Network | Oct 4, 2010
What happens when two great scientists sit down for a one-on-one to talk about their work, their mentors and what motivates them? Yes, you get some great chemistry, but more than that, you get a fascinating look at the people and process behind the identification of...
by Stem Cell Network | Oct 1, 2010
For the second year running, mainstream media in Canada and abroad has picked up on Nobel buzz surrounding stem cell scientists James Till and Ernest McCulloch, both Senior Scientists at the Ontario Cancer Institute in Toronto. Speculation surrounding a Nobel prize...
by Katie Moisse | Sep 17, 2010
Replacing dead or dying cells with new, healthy ones is the holy grail of regenerative medicine. Even sustaining damaged cells with toxin-mopping, growth-factor-spewing stem-cell-derived support cells would be a tremendous feat. But while clinical trials have hinted...
by Ubaka Ogbogu | Sep 10, 2010
The US Court of Appeals in Washington DC yesterday suspended a recent temporary injunction issued by a federal district judge against the use of federal funds for hESC research. Read my earlier post on the injunction. The suspension is temporary, and is intended to...
Comments